For the last two years, Neumora Therapeutics Inc. has been operating in stealth mode, quietly amassing a treasure trove of venture capital. Now that it’s well past the point of scientific validation, Neumora is ready to make its public debut.

Boston Biz Journal https://www.bizjournals.com/boston/news/2021/10/07/biotech-startup-neumora-500m-amgen-launch.html?ana=RSS&s=article_search